Scientific Program

1. Cigarette Smoke Exposure and Lung Health.
Michael Fayon - Bordeaux, France

2. Outdoor Pollution and its Impact on Lung Diseases.
Peter Sly - Brisbane, Australia

3. Is All Environment a Menace? Biodiversity and Lung Health.
Erika von Mutius - Munich, Germany

1. Sleep in Children - Year in Review.
Jean-Paul Praud - Sherbrooke, Canada

2. Sleep Disorder Breathing in Neonates and Infants: Long-term Consequences.
Refika Ersu - Ottawa, Canada

3. Sleep Disorders in Children with Chronic Respiratory Diseases.
Joel Reiter - Jerusalem, Israel

4. Sleep Disorders Breathing in Children with Down Syndrome.
Rosemary Horne - Melbourne, Australia

1. Origin of Pulmonary Vascular Disease.
Steven Abman - Aurora, USA

2. Excercise Testing and Rehabilitation in Children.
Pascal Amedro - Bordeaux, France

3. Update in Primary Ciliary Dyskinesia.
Mieke Boon - Leuven, Belgium

4. Sickle Cell Disease: Pulmonary Management.
Cara Bossley - London, UK

Moderators:
Brucce Rubin - Richmond, USA
Cass Byrnes - Auckland, New Zealand
Dimos Gidaris - Thessaloniki, Greece

1. State-of-the-Art Lung MRI: From the Glottis to Alveous.
Jason Woods - Cincinnati, USA

2. Update in Pre-school Wheeze.
Sejal Saglani - London, UK

3. Invasive Therapies for Thoracic Lymphatic Disorder.
Yoav Dori - Philadelphia, USA

4. Young Investigators Oral Communications

K 366 - Establishment of Computational Fluid Dynamics Simulation Method for CO2 Washout Effect in High Flow Therapy.
Hisato Kobayashi - Tokyo, Japan

O 386 - Longitudinal Clinical and Pulmonary Characteristics of Children with Post-Covid 19 Conditions.
Betty Marita Wörner - Jena, Germany

Moderators:
Jean-Paul Praud - Sherbrooke, Canada
June Marthin - Copenhagen, Denmark

1. Biologicals in Severe Asthma: Evidence and Clinical Practice.
Theresa Guilbert - Cincinnati, USA

2. Intermittent Hypoxia during Sleep: Lessons from Rodent Models.
David Gozal - Columbia, USA

3. Novel Immune Interventions for Virus Induced Respiratory Diseases.
Renato Stein - Porto Alegre, Brazil

4. Young Investigator's Oral Communications

J 266 - Is EBUS-TBNA the Future Gold Standard Diagnostic Modality In Pediatric Mediastinal Lymphadenopathy ?
Kaustubh Mohite - Bangalore, India

J 313 - Electronic Pediatric Lung Sounds Classification Using a Machine Learning Approach.
Ji Soo Park - Seoul, South Korea

1. Primary Prevention of Asthma.
Erika von Mutius - Munich, Germany

2. The Lung Microbiome in Health and Disease.
James Gern - Madison, USA

3. Microbiome in Chronic Cough.
Robyn Marsh - Brisbane, Australia

4. How the Gut Microbiome Affects the Lung.
Giovanni Rossi - Genoa, Italy

1. Air and Soul: The Science and Practice of Aerosol Therapy.
Bruce Rubin - Richmond, USA

2. Inhaled Interventions: Interferon...
Sebastian Johnston - London, UK

3. Aerosol Therapy  during High Flow Nasal Canula.
James B Fink - San Mateo, USA

4. Aerosol Therapy and Covid-19.
Arzu Ari - Round Rock, USA

1. Origins of COPD in Childhood.
Fernando Martinez - Tucson, USA

2. Respiratory Tract Infection and the Development of Wheeze.
Nikolaos Papadopoulos - Athens, Greece

3. HIV and Lung Disease.
Leah Githinji Ferguson - Cape Town, South Africa

Chairman:
Michael Fayon - Bordeaux France

Discussion:
Andrew Bush - London, UK
Andrew Colin - Miami, USA
Giovanni Rossi - Genoa, Italy
Bruce Rubin- Richmond, USA